Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 6
2014 3
2015 5
2016 2
2017 5
2018 10
2019 9
2020 3
2021 8
2022 6
2023 8
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

63 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean wilke b[au] (160 results)?
Immunotherapy in Sarcoma: Where Do Things Stand?
Moreno Tellez C, Leyfman Y, D'Angelo SP, Wilky BA, Dufresne A. Moreno Tellez C, et al. Among authors: wilky ba. Surg Oncol Clin N Am. 2022 Jul;31(3):381-397. doi: 10.1016/j.soc.2022.03.004. Surg Oncol Clin N Am. 2022. PMID: 35715140 Review.
Nirogacestat, a γ-Secretase Inhibitor for Desmoid Tumors.
Gounder M, Ratan R, Alcindor T, Schöffski P, van der Graaf WT, Wilky BA, Riedel RF, Lim A, Smith LM, Moody S, Attia S, Chawla S, D'Amato G, Federman N, Merriam P, Van Tine BA, Vincenzi B, Benson C, Bui NQ, Chugh R, Tinoco G, Charlson J, Dileo P, Hartner L, Lapeire L, Mazzeo F, Palmerini E, Reichardt P, Stacchiotti S, Bailey HH, Burgess MA, Cote GM, Davis LE, Deshpande H, Gelderblom H, Grignani G, Loggers E, Philip T, Pressey JG, Kummar S, Kasper B. Gounder M, et al. Among authors: wilky ba. N Engl J Med. 2023 Mar 9;388(10):898-912. doi: 10.1056/NEJMoa2210140. N Engl J Med. 2023. PMID: 36884323 Clinical Trial.
Axitinib plus pembrolizumab in patients with advanced sarcomas including alveolar soft-part sarcoma: a single-centre, single-arm, phase 2 trial.
Wilky BA, Trucco MM, Subhawong TK, Florou V, Park W, Kwon D, Wieder ED, Kolonias D, Rosenberg AE, Kerr DA, Sfakianaki E, Foley M, Merchan JR, Komanduri KV, Trent JC. Wilky BA, et al. Lancet Oncol. 2019 Jun;20(6):837-848. doi: 10.1016/S1470-2045(19)30153-6. Epub 2019 May 8. Lancet Oncol. 2019. PMID: 31078463 Clinical Trial.
Emerging mechanisms of immunotherapy resistance in sarcomas.
Florou V, Wilky BA. Florou V, et al. Among authors: wilky ba. Cancer Drug Resist. 2022 Mar 5;5(1):199-213. doi: 10.20517/cdr.2021.111. eCollection 2022. Cancer Drug Resist. 2022. PMID: 35582530 Free PMC article. Review.
Future directions in soft tissue sarcoma treatment.
Hall F, Villalobos V, Wilky B. Hall F, et al. Among authors: wilky b. Curr Probl Cancer. 2019 Aug;43(4):300-307. doi: 10.1016/j.currproblcancer.2019.06.004. Epub 2019 Jun 20. Curr Probl Cancer. 2019. PMID: 31229264 Review.
Current and Future Directions for Angiosarcoma Therapy.
Florou V, Wilky BA. Florou V, et al. Among authors: wilky ba. Curr Treat Options Oncol. 2018 Mar 8;19(3):14. doi: 10.1007/s11864-018-0531-3. Curr Treat Options Oncol. 2018. PMID: 29520447 Review.
Latest advances in adult gastrointestinal stromal tumors.
Florou V, Wilky BA, Trent JC. Florou V, et al. Among authors: wilky ba. Future Oncol. 2017 Oct;13(24):2183-2193. doi: 10.2217/fon-2017-0245. Epub 2017 Oct 6. Future Oncol. 2017. PMID: 28984483 Review.
63 results